65650-04-6

Basic information

• Product Name: 2-Furancarboxylic acid, 5-(4-methoxybenzoyl)-, methyl ester
• CAS NO: 65650-04-6
• Molecular Formula: C14H12O5
• Molecular Weight: 260.246
• Mol File: 65650-04-6.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2-Furancarboxylic acid, 5-(4-methoxybenzoyl)-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Furancarboxylic acid, 5-(4-methoxybenzoyl)-, methyl ester(65650-04-6)
• EPA Substance Registry System: 2-Furancarboxylic acid, 5-(4-methoxybenzoyl)-, methyl ester(65650-04-6)

Safety Data

• Hazardous Substances Data: 65650-04-6(Hazardous Substances Data)

Upstream product

• 611-13-2 2-furoic acid methyl ester 
• 100-07-2 4-methoxy-benzoyl chloride 

Downstream Products

• 170632-20-9 5-[(benzyl-hydrazono)-(4-methoxy-phenyl)-methyl]-furan-2-carboxylic acid methyl ester 
• 871507-55-0 5-[acetoxy-benzylazo-(4-methoxy-phenyl)-methyl]-furan-2-carboxylic acid methyl ester 
• 15045-67-7 methyl 5-(4-methoxybenzyl)furan-2-carboxylate 
• 3988-92-9 5-p-Methoxybenzyl-2-furancarbonsaeure 
• 65650-10-4 5-(4-methoxy-benzoyl)-furan-2-carboxylic acid 
• 1311388-86-9 C₁₃H₉ClO₄ 
• 1333247-80-5 N-ethyl-5-(hydroxy(4-methoxyphenyl)methyl)-N-(3,4,5-trimethoxyphenyl)furan-2-carboxamide 
• 170632-31-2 1-benzyl-3-(5'-methoxycarbonyl-2'-furyl)-6-methoxyindazole 
• 170632-49-2 [5-(1-benzyl-6-methoxy-1H-indazol-3-yl)-furan-2-yl]-methanol 
• 630403-16-6 {5-[Hydroxy-(4-methoxy-phenyl)-methyl]-furan-2-yl}-((S)-2-hydroxymethyl-pyrrolidin-1-yl)-methanone 
• 630403-10-0 5-[hydroxy-(4-methoxy-phenyl)-methyl]-furan-2-carboxylic acid ethyl-(2-hydroxy-ethyl)-amide 
• 630403-07-5 5-[hydroxy-(4-methoxy-phenyl)-methyl]-furan-2-carboxylic acid methyl ester 

Relevant articles and documents

1-Benzyl-3-(5′-hydroxymethyl-2′-furyl)-indazole (YC-1) derivatives as novel inhibitors against sodium nitroprusside-induced apoptosis

Antiapoptotic agents based on 1-benzyl-3-(5′-hydroxymethyl-2′-furyl)indazole (22, YC-1) derivatives were explored for effective treatment of sepsis and septic shock. We found that compound 22, 1-benzyl-3-(5′-methoxymethyl-2′-furyl)indazole (27), and 1-phe

1-(substituted benzyl)-3-(substituted aryl)-condensed pyrazole derivatives and processes of making the same

The invention pertains to a process for preparing (1-substituted benzyl)-3-(hydroxy-carbonyl aryl) condensed pyrazoles or (1-substituted benzyl)-3-(hydroxymethyl aryl) condensed pyrazoles comprising the steps of: (a) reacting compound I and compound II, or compound III and compound IV, to produce compound V, which is a substituted aryl ketone, as follows: STR1 wherein Ar2 and At3 can be, independently, STR2 R1 is H, C1-3 alkyl, or X (halogen), R3 is H, C1-3 alkyl, X (halogen), or --OR radical, and R is H or C1-3 alkyl; the process comprising the following steps of: R2 represents CH2 OR, H, COOR, C1-3 alkyl, or X (halogen); (b) reacting the compound V with a hydrazine compound to form a hydrazone compound; (c) reacting the hydrazone compound compound with trifluoride etherate (BF3 ·Et2 O) to form a 1-(substituted benzyl) 3-(substituted aryl) condensed pyraxzole, which is represented by the following formula of STR3 Compound X can be further hydrolyzed or reduced to form corresponding carboxylic acids or alcohols.